News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
39,304 Results
Type
Article (1634)
Company Profile (5)
Press Release (37664)
Section
Business (16395)
Career Advice (82)
Deals (2118)
Drug Delivery (1)
Drug Development (4908)
Employer Resources (1)
FDA (667)
Job Trends (819)
News (23294)
Policy (1196)
Tag
Academia (41)
Accelerated approval (2)
Allergies (6)
Alliances (1195)
ALS (5)
Alzheimer's disease (72)
Antibody-drug conjugate (ADC) (16)
Approvals (709)
Artificial intelligence (8)
Autoimmune disease (7)
Automation (1)
Bankruptcy (7)
Best Places to Work (782)
BIOSECURE Act (2)
Biosimilars (7)
Biotechnology (3)
Bladder cancer (10)
Brain cancer (4)
Breast cancer (44)
Cancer (299)
Cardiovascular disease (23)
Career advice (82)
CAR-T (11)
Cell therapy (27)
Cervical cancer (1)
Clinical research (4597)
Collaboration (43)
Compensation (19)
Complete response letters (5)
COVID-19 (73)
CRISPR (4)
C-suite (9)
Cystic fibrosis (7)
Data (534)
Depression (10)
Diabetes (37)
Diagnostics (278)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (7)
Drug pricing (2)
Drug shortages (2)
Duchenne muscular dystrophy (14)
Earnings (15500)
Editorial (2)
Employer resources (1)
Events (6226)
Executive appointments (9)
FDA (979)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (4)
Funding (27)
Gene editing (8)
Generative AI (1)
Gene therapy (28)
GLP-1 (45)
Government (118)
Guidances (162)
Healthcare (878)
HIV (1)
IgA nephropathy (6)
Immunology and inflammation (12)
Immuno-oncology (2)
Indications (9)
Infectious disease (85)
Inflammatory bowel disease (8)
Influenza (6)
Intellectual property (11)
Interviews (14)
IPO (1499)
IRA (1)
Job creations (94)
Job search strategy (60)
JPM (3)
Layoffs (9)
Leadership (1)
Legal (168)
Liver cancer (4)
Lung cancer (56)
Lymphoma (34)
Manufacturing (18)
MASH (20)
Medical device (741)
Medtech (745)
Mergers & acquisitions (635)
Metabolic disorders (87)
Multiple sclerosis (12)
NASH (2)
Neurodegenerative disease (12)
Neuropsychiatric disorders (8)
Neuroscience (157)
NextGen: Class of 2026 (179)
Non-profit (93)
Obesity (31)
Opinion (6)
Ovarian cancer (7)
Pain (12)
Pancreatic cancer (9)
Parkinson's disease (15)
Partnered (1)
Patents (17)
Patient recruitment (17)
Peanut (1)
People (944)
Pharmaceutical (4)
Pharmacy benefit managers (2)
Phase 1 (960)
Phase 2 (2049)
Phase 3 (1880)
Pipeline (730)
Policy (7)
Postmarket research (186)
Preclinical (470)
Press Release (4)
Prostate cancer (21)
Psychedelics (3)
Radiopharmaceuticals (18)
Rare diseases (49)
Real estate (147)
Recruiting (1)
Regulatory (1113)
Reports (3)
Research institute (47)
Resumes & cover letters (8)
RSV (4)
Schizophrenia (23)
Series A (4)
Series B (2)
Sickle cell disease (12)
Special edition (1)
Spinal muscular atrophy (6)
Sponsored (1)
Startups (79)
Stomach cancer (2)
Supply chain (3)
Tariffs (1)
The Weekly (2)
Vaccines (34)
Weight loss (15)
Women's health (5)
Date
Today (11)
Last 7 days (36)
Last 30 days (105)
Last 365 days (2334)
2026 (166)
2025 (2369)
2024 (2516)
2023 (2864)
2022 (3228)
2021 (3915)
2020 (2600)
2019 (2170)
2018 (1481)
2017 (1300)
2016 (998)
2015 (1310)
2014 (910)
2013 (519)
2012 (610)
2011 (796)
2010 (682)
Location
Africa (24)
Alabama (3)
Arizona (10)
Arkansas (1)
Asia (2455)
Australia (284)
California (798)
Canada (187)
China (70)
Colorado (40)
Connecticut (34)
Delaware (34)
Europe (5248)
Florida (96)
Georgia (36)
Idaho (1)
Illinois (65)
India (1)
Indiana (70)
Japan (50)
Kansas (1)
Kentucky (5)
Louisiana (7)
Maine (12)
Maryland (106)
Massachusetts (552)
Michigan (21)
Minnesota (61)
Missouri (5)
Montana (2)
Nebraska (1)
Nevada (4)
New Hampshire (10)
New Jersey (312)
New York (220)
North Carolina (77)
Northern California (426)
Ohio (16)
Oklahoma (1)
Pennsylvania (193)
South America (61)
South Carolina (1)
Southern California (304)
Tennessee (11)
Texas (99)
United States (2947)
Utah (32)
Virginia (10)
Washington D.C. (3)
Washington State (64)
Wisconsin (7)
39,304 Results for "111".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Coya Therapeutics Announces $11.1 Million Private Placement
February 1, 2026
·
8 min read
Press Releases
111, Inc. Announces Third Quarter 2025 Unaudited Financial Results
December 17, 2025
·
22 min read
Press Releases
RISA Labs Closes $11.1M Series A to Scale AI Operating System for Oncology Nationwide
January 14, 2026
·
4 min read
Press Releases
Ultragenyx Resubmits Biologics License Application for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA) to U.S. FDA
February 1, 2026
·
8 min read
Press Releases
PDS Biotechnology Announces up to $11.1 Million Registered Direct Offering
November 11, 2025
·
8 min read
Press Releases
Biomea Fusion Presents COVALENT-111 Study Results at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)
December 5, 2025
·
6 min read
Press Releases
Ultragenyx Announces Positive Longer-Term Data Demonstrating Treatment with UX111 Gene Therapy Results in Sustained, Significant Reductions in CSF-HS and Continued Meaningful Improvements in Clinical Function Across Multiple Developmental Domains in Children with Sanfilippo Syndrome (MPS IIIA)
February 3, 2026
·
10 min read
Press Releases
111, Inc. Announces Second Quarter 2025 Unaudited Financial Results
September 17, 2025
·
20 min read
Gene therapy
Ultragenyx’s Gene Therapy Shows Long-Term Efficacy in Two Sanfilippo Studies
The FDA in July last year declined to approve UX111 for Sanfilippo syndrome, a rare neurodegenerative disorder, citing manufacturing issues. Ultragenyx Pharmaceutical resubmitted its application ten days ago, expecting a six month review time.
February 9, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Boehringer Ingelheim and CDR-Life Expand Collaboration Efforts with Global Licensing Agreement for CDR111, an Antibody-Based Trispecific M-gager® for Autoimmune Diseases
November 5, 2025
·
3 min read
1 of 3,931
Next
